These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 25268204)
1. [Modern anti-cancer therapy: current state and future developments]. Bokemeyer C; Hiddemann W Dtsch Med Wochenschr; 2014 Oct; 139(41):2067. PubMed ID: 25268204 [No Abstract] [Full Text] [Related]
2. [Targeted therapy: old and new possibilities]. Hochhaus A; Lüftner D; Mackensen A Onkologie; 2013; 36 Suppl 5():2-11. PubMed ID: 23921800 [No Abstract] [Full Text] [Related]
3. Development trends for monoclonal antibody cancer therapeutics. Reichert JM; Valge-Archer VE Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406 [TBL] [Abstract][Full Text] [Related]
4. Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development. Stahel R; Bogaerts J; Ciardiello F; de Ruysscher D; Dubsky P; Ducreux M; Finn S; Laurent-Puig P; Peters S; Piccart M; Smit E; Sotiriou C; Tejpar S; Van Cutsem E; Tabernero J Cancer Treat Rev; 2015 Feb; 41(2):129-35. PubMed ID: 25533737 [TBL] [Abstract][Full Text] [Related]
5. Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments. Selzer E; Kornek G Expert Rev Clin Pharmacol; 2013 Nov; 6(6):663-76. PubMed ID: 24164614 [TBL] [Abstract][Full Text] [Related]
7. X chemotherapy, myth and realities. Thomas M; Pavithran K J Indian Med Assoc; 2005 Sep; 103(9):489-90, 492, 494. PubMed ID: 16493871 [TBL] [Abstract][Full Text] [Related]
9. Targeted and tailored therapy in hemato-oncology: vision for the 21st century. Shpilberg O; Ben-Bassat I; Raanani P Isr Med Assoc J; 2006 Dec; 8(12):843-4. PubMed ID: 17214100 [TBL] [Abstract][Full Text] [Related]
10. New targets and targeted drugs for the treatment of cancer: an outlook to pediatric oncology. Rossig C; Juergens H; Berdel WE Pediatr Hematol Oncol; 2011 Oct; 28(7):539-55. PubMed ID: 21936619 [TBL] [Abstract][Full Text] [Related]
11. [Advances in medical oncology]. Shi YK Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620 [TBL] [Abstract][Full Text] [Related]
12. [New drugs in oncology: benefits, risks and challenges]. Cella D; Vervölgyi V; Wörmann B Onkologie; 2013; 36 Suppl 5():12-9. PubMed ID: 23921801 [No Abstract] [Full Text] [Related]
13. The RACE to accelerate drug development for children with cancer. Pearson ADJ; Karres D; Reaman G; DuBois SG; Knox L; Scobie N; Vassal G Lancet Child Adolesc Health; 2020 Oct; 4(10):714-716. PubMed ID: 32822672 [No Abstract] [Full Text] [Related]
14. ASCO 2011: broadening the horizons of cancer research. Crane K J Natl Cancer Inst; 2011 Jul; 103(13):999-1001. PubMed ID: 21693729 [No Abstract] [Full Text] [Related]
15. Targeted biopharmaceuticals for cancer treatment. Zhou L; Xu N; Sun Y; Liu XM Cancer Lett; 2014 Oct; 352(2):145-51. PubMed ID: 25016064 [TBL] [Abstract][Full Text] [Related]
16. [Dermatology -- the most progressive discipline in medicine]. Röcken M J Dtsch Dermatol Ges; 2015 Jul; 13(7):617-9. PubMed ID: 26110720 [No Abstract] [Full Text] [Related]
17. [Status quo and prospects for systemic therapy of atopic dermatitis. Biologics ante portas]. Biedermann T; Werfel T Hautarzt; 2015 Feb; 66(2):108-13. PubMed ID: 25645542 [TBL] [Abstract][Full Text] [Related]
18. The next generation of antibody-drug conjugates comes of age. Beck A; Haeuw JF; Wurch T; Goetsch L; Bailly C; Corvaïa N Discov Med; 2010 Oct; 10(53):329-39. PubMed ID: 21034674 [TBL] [Abstract][Full Text] [Related]
19. [Targeted based therapies in metastatic breast cancer: future evolution]. Belmondo L; Montana M; Curti C; Crozet M; Rathelot P; Penot-Ragon C; Vanelle P Therapie; 2012; 67(6):491-503. PubMed ID: 23249575 [TBL] [Abstract][Full Text] [Related]